FIRST DIAGNOSIS OF UVEITIS IS NOT HIGHER AMONG JUVENILE IDIOPATHIC ARTHRITIS (JIA) PATIENTS RECEIVING ETANERCEPT COMPARED TO METHOTREXATE

被引：0
|
作者：
Davies, R. [1 ]
De Cock, D. [1 ]
Kearsley-Fleet, L. [1 ]
Ramanan, A. [2 ,3 ]
Hyrich, K. L. [1 ,4 ]
机构：
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Hosp Bristol NHS Fdn Trust, Pediat Rheumatol, Bristol, Avon, England
[3] Univ Bristol, Sch Clin Sci, Ophthalmol, Bristol, Avon, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Musculoskeletal Bio, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0351
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [1] FIRST DIAGNOSIS OF UVEITIS IS NOT HIGHER AMONG JUVENILE IDIOPATHIC ARTHRITIS PATIENTS RECEIVING ETANERCEPT COMPARED TO METHOTREXATE
    Davies, Rebecca
    De Cock, Diederik
    Kearsley-Fleet, Lianne
    Ramanan, Athimalaipet
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2018, 57 : 16 - 16
  • [2] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Klotsche, Jens
    Niewerth, Martina
    Haas, Johannes-Peter
    Huppertz, Hans-Iko
    Zink, Angela
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861
  • [3] LONG-TERM SAFETY OF ETANERCEPT AND ADALIMUMAB COMPARED TO METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, J.
    Niewerth, M.
    Seipelt, E.
    Horneff, G.
    Minden, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 114 - 114
  • [4] ETANERCEPT, ADALIMUMAB AND METHOTREXATE UTILIZATION BY JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AND THE OCCURRENCE OF UVEITIS
    Roshak, K.
    Sopczynski, J. M.
    Suehiro, R. M.
    Marshall, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 402 - 403
  • [5] ETANERCEPT, ADALIMUMAB, AND METHOTREXATE UTILIZATION BY JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AND THE OCCURRENCE OF UVEITIS
    Roshak, K.
    Sopczynski, J. M.
    Suehiro, R.
    Marshall, L. M.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S123 - S123
  • [6] Etanercept and uveitis in patients with juvenile idiopathic arthritis
    Schmeling, H
    Horneff, G
    RHEUMATOLOGY, 2005, 44 (08) : 1008 - 1011
  • [7] Etanercept and uveitis in patients with juvenile idiopathic arthritis
    Schmeling, H
    Winkler, A
    Horneff, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 384 - 384
  • [8] Combination therapy with etanercept and methotrexate compared to etanercept monotherapy in patients with juvenile idiopathic arthritis
    Horneff, G
    Girschick, H
    Foeldvari, I
    Michels, H
    Rogalski, B
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S724 - S725
  • [9] Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
    Horneff, G.
    De Bock, F.
    Foeldvari, I.
    Girschick, H. J.
    Michels, H.
    Moebius, D.
    Schmeling, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 519 - 525
  • [10] Effectiveness and compatibility of etanercept and methotrexate or etanercept for patients with juvenile idiopathic arthritis
    De Bock, F.
    Foeldvari, I.
    Girschick, H. J.
    Kuester, R.
    Michels, H.
    Moebius, D.
    Schmeling, H.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (07): : 628 - 629
12345